View Item 

Show simple item record

Executive summary of the NHLBI State of the Science (SOS) Workshop: Overview and next steps in generating a national blueprint for future research on factor VIII inhibitors
dc.contributor.authorPipe, Steven W.
dc.contributor.authorSabatino, Denise E.
dc.contributor.authorNugent, Diane J.
dc.contributor.authorHooper, W. Craig
dc.contributor.authorSoucie, J. Michael
dc.contributor.authorKeith Hoots, W.
dc.contributor.authorDiMichele, Donna M.
dc.date.accessioned2019-08-09T17:15:45Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2019-08-09T17:15:45Z
dc.date.issued2019-07
dc.identifier.citationPipe, Steven W.; Sabatino, Denise E.; Nugent, Diane J.; Hooper, W. Craig; Soucie, J. Michael; Keith Hoots, W.; DiMichele, Donna M. (2019). "Executive summary of the NHLBI State of the Science (SOS) Workshop: Overview and next steps in generating a national blueprint for future research on factor VIII inhibitors." Haemophilia 25(4): 610-615.
dc.identifier.issn1351-8216
dc.identifier.issn1365-2516
dc.identifier.urihttps://hdl.handle.net/2027.42/150611
dc.publisherWiley Periodicals, Inc.
dc.subject.otherresearch
dc.subject.otherblueprint
dc.subject.otherhaemophilia
dc.subject.otherimplementation
dc.subject.otherinhibitor
dc.subject.otherfactor VIII
dc.titleExecutive summary of the NHLBI State of the Science (SOS) Workshop: Overview and next steps in generating a national blueprint for future research on factor VIII inhibitors
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/150611/1/hae13713_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/150611/2/hae13713.pdf
dc.identifier.doi10.1111/hae.13713
dc.identifier.sourceHaemophilia
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/pa-files/PAR-18-407.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://www.cdc.gov/ncbddd/hemophilia/inhibitors.html. Accessed November 17, 2018.
dc.identifier.citedreferenceGaragiola I, Palla R, Peyvandi F. Risk factors for inhibitor development in severe hemophilia A. Thromb Res. 2018; 168: 20 ‐ 27.
dc.identifier.citedreferenceMaking strides toward preventing inhibitors in bleeding disorders. https://www.cdc.gov/features/preventing-inhibitors/index.html. Accessed November 17, 2018.
dc.identifier.citedreferenceRagni M, George L; on behalf of the Members of Working Group 1. The national blueprint for future factor VIII inhibitor clinical trials: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors. Haemophilia. 2019; 25 ( 4 ): 581 ‐ 589.
dc.identifier.citedreferenceKonkle BA, Recht M; on behalf of the Members of Working Group 2. The national blueprint for 21st century data and specimen collection and observational cohort studies: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors. Haemophilia. 2019; 25 ( 4 ): 590 ‐ 594.
dc.identifier.citedreferenceMeeks SL, Herzog RW; on behalf of the Members of Working Group 3. The national blueprint for future basic and translational research to understand factor VIII immunogenicity: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors. Haemophilia. 2019; 25 ( 4 ): 595 ‐ 602.
dc.identifier.citedreferenceJohnsen JM, Brown DL; on behalf of the Members of Working Group 4. The national blueprint for pregnancy/birth longitudinal cohorts to study factor VIII immunogenicity: NHLBI State of the Science (SOS) Workshop on factor VIII inhibitors. Haemophilia. 2019; 25 ( 4 ): 603 ‐ 609.
dc.identifier.citedreferenceWilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016; 3: 160018.
dc.identifier.citedreferenceBioLINCC – Biologic Specimen and Data Repository Information Coordinating Center. https://biolincc.nhlbi.nih.gov/home/. Accessed November 17, 2018
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-014.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-652.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/pa-files/PAR-18-768.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-027.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/notice-files/NOT-HL-18-624.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://original-phenxtoolkit.rti.org/index.php. Accessed November 17, 2018.
dc.identifier.citedreferencehttp://www.healthmeasures.net/explore-measurement-systems/nih-toolbox. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/pa-files/PAR-18-683.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/pa-files/par-18-406.html. Accessed November 17, 2018.
dc.identifier.citedreferencehttps://grants.nih.gov/grants/guide/pa-files/PAR-18-410.html. Accessed on November 17, 2018.
dc.identifier.citedreferencehttps://researchtraining.nih.gov. Accessed November 17, 2018.
dc.identifier.citedreferenceHoos A, Anderson J, Boutin M, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Ther Innov Regul Sci. 2015; 49 ( 6 ): 929 ‐ 939.
dc.identifier.citedreferenceLeese J, Macdonald G, Kerr S, et al. ‘Adding another spinning plate to an already busy life’. Benefits and risks in patient partner‐researcher relationships: a qualitative study of patient partner’s experiences in a Canadian health research setting. BMJ Open. 2018; 8 ( 8 ): e022154.
dc.identifier.citedreferenceDay S, Jonker AH, Lau PL, et al. Recommendations for the design of small population clinical trials. Orphanet J Rare Dis. 2018; 13 ( 1 ): 195.
dc.identifier.citedreferenceState of the science inhibitors workshop: FVIII inhibitors: generating a national blueprint for future research (day 1). https://videocast.nih.gov/Summary.asp?Live=27769&bhcp=1. Accessed November 17, 2018.
dc.identifier.citedreferenceState of the science inhibitors workshop: FVIII inhibitors: generating a national blueprint for future research (day 2). https://videocast.nih.gov/summary.asp?Live=277757&bhcp=1. Accessed November 17, 2018.
dc.identifier.citedreferenceSabatino DE, Pipe SW, Nugent DJ, et al. Origins and organization of the NHLBI State of the Science (SOS) Workshop: generating a national blueprint for future research on factor VIII inhibitors. Haemophilia. 2019; 25 ( 4 ): 575 ‐ 580.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hae13713_am.pdf
Size:
302.7KB
Format:
PDF
View/Open
Name:
hae13713.pdf
Size:
539.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.